Specific Diagnostics Receives $12.5M Investment

The funding will support the commercialization of Specific’s Reveal™ platform, which will provide a rapid, accurate antibiotic susceptibility test critical to the treatment of deadly drug resistant infections..

Sourced through Scoop.it from: vcnewsdaily.com